Pyruvate sensitizes pancreatic tumors to a hypoxia activated pro-drug TH-302.

J. W. Wojtkowiak, H. C. Cornell, S. Matsumoto, K. Saito, Y. Takakusagi, P. Dutta, M. Kim, X. Zhang, R. Leo, K. M. Bailey, G. Martinez, M. C. Lloyd, R. M. Lynch, A. Baker, R. A. Gatenby, K. Rejniak, C. Hart, M. C. Krishna, R. J. Gillies

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)2-15
JournalCancer Metab.
Volume3
DOIs
StatePublished - Jan 29 2015

Cite this

Wojtkowiak, J. W., Cornell, H. C., Matsumoto, S., Saito, K., Takakusagi, Y., Dutta, P., Kim, M., Zhang, X., Leo, R., Bailey, K. M., Martinez, G., Lloyd, M. C., Lynch, R. M., Baker, A., Gatenby, R. A., Rejniak, K., Hart, C., Krishna, M. C., & Gillies, R. J. (2015). Pyruvate sensitizes pancreatic tumors to a hypoxia activated pro-drug TH-302. Cancer Metab., 3, 2-15. https://doi.org/10.1186/s40170-014-0026-z